ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

ASA Honors Bernard Fisher With Surgeons’ Highest Award.

April 21, 2000

Pitt Seeks Biostatistician For NSABP, Hearing Delayed a Week

September 23, 1994

Chabner, FDA’s Temple continue disagreement Over Drug Approval

February 10, 1989

Clinical Cooperative Groups Asked To Develop Tamoxifen Prevention Trial; CGOPs To Participate

July 6, 1990

NCI Agrees To Offer New Screening RFP In The Future

May 28, 1976

NCI’s $65 Million to NTP Will Be Controversial, Untouchable; Spectre Of Another Backlog Looms

February 8, 1980